Pancreatic neuroendocrine tumor (pNET) is a rare type of pancreatic tumors. The incidence of pNET shows a gradually increasing trend in recent years. The most common organ of distant metastases is the liver. Surgical resection is still the optimal treatment for resectable, well-differentiated liver metastases with no evidence of extrahepatic spread. For unresectable patients, a combination of multiple modalities, such as transarterial chemoembolization, radiofrequency ablation, systemic chemotherapy, and molecular targeted therapy, can prolong the survival time of patients. Liver transplantation should be strictly evaluated on an individual basis
Neuroendocrine tumors (NETs) in general and specifically these gastroenteropancreatic-neuroendocrine...
AbstractBackgroundThe incidence of neuroendocrine tumours (NET) has increased over the past three de...
This study investigates survival of patients diagnosed with pancreatic neuroendocrine tumor with liv...
Abstract Background Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40...
Abstract. Pancreatic neuroendocrine tumors (PNETs) are a rare group of neoplasms originating from th...
Pancreatic neuroendocrine neoplasms (p-NENs) are slowly growing tumors with frequent liver metastasi...
Pancreatic neuroendocrine tumors (pNETs) are frequently malignant (50-80%, except for insulinoma) an...
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients wit...
Background. Pancreatic neuroendocrine tumors (PNETs) present in more than 50% of cases with liver me...
Background: Liver metastases are a strong prognostic indicator in patients with gastro-entero-pancre...
Purpose. Nonsurgical therapies, including biotherapy, chemotherapy, and liver-directed therapy, prov...
In neuroendocrine tumors (NETs), liver metastases (LM) represent the most crucial prognostic factor,...
Patients diagnosed with Neuroendocrine Tumors (NET) often are also diagnosed with Neuroendocrine Liv...
Pancreatic neuroendocrine tumors (pNETs) are a vast growing disease. Over 50% of these tumors are re...
Neuroendocrine neoplasms (NENs) are a distinctive entity, and nearly 10% of patients already have li...
Neuroendocrine tumors (NETs) in general and specifically these gastroenteropancreatic-neuroendocrine...
AbstractBackgroundThe incidence of neuroendocrine tumours (NET) has increased over the past three de...
This study investigates survival of patients diagnosed with pancreatic neuroendocrine tumor with liv...
Abstract Background Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40...
Abstract. Pancreatic neuroendocrine tumors (PNETs) are a rare group of neoplasms originating from th...
Pancreatic neuroendocrine neoplasms (p-NENs) are slowly growing tumors with frequent liver metastasi...
Pancreatic neuroendocrine tumors (pNETs) are frequently malignant (50-80%, except for insulinoma) an...
Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40-80% of patients wit...
Background. Pancreatic neuroendocrine tumors (PNETs) present in more than 50% of cases with liver me...
Background: Liver metastases are a strong prognostic indicator in patients with gastro-entero-pancre...
Purpose. Nonsurgical therapies, including biotherapy, chemotherapy, and liver-directed therapy, prov...
In neuroendocrine tumors (NETs), liver metastases (LM) represent the most crucial prognostic factor,...
Patients diagnosed with Neuroendocrine Tumors (NET) often are also diagnosed with Neuroendocrine Liv...
Pancreatic neuroendocrine tumors (pNETs) are a vast growing disease. Over 50% of these tumors are re...
Neuroendocrine neoplasms (NENs) are a distinctive entity, and nearly 10% of patients already have li...
Neuroendocrine tumors (NETs) in general and specifically these gastroenteropancreatic-neuroendocrine...
AbstractBackgroundThe incidence of neuroendocrine tumours (NET) has increased over the past three de...
This study investigates survival of patients diagnosed with pancreatic neuroendocrine tumor with liv...